RianCorp markets a Low Level Laser Therapy (LLLT) product indicated for the treatment of Lympedema and musculoskeletal pain.
RianCorp is a small single technology company which would have had
difficulty supporting the quality and regulatory overhead required for
the manufacture of this product. Through our Manufacture By Agreement
model, Ingeneus provided a solution for RianCorp’s manufacturing,
logistics, service and post market surveillance for their LTU-904 model
LLLT uses a laser to bring about a photochemical reaction at a
cellular level. The laser light penetrates into tissue where it is
absorbed by cells and converted into energy that influences the course
of metabolic processes.